In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire

Journal of Immunological Methods

Volumn 310, Issue 1-2, 2006, Pages 40-52

  Ho, William Y ^a   Nguyen, Hieu N ^a   Wolfl, Matthias ^a   Kuball, Juergen ^a   Greenberg, Philip D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adoptive immunotherapy; CTL priming; In vitro; Tumor immunity; WT1

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; HLA A ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 6; MELAN A; POLYMER; PROSTAGLANDIN E2; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; WT1 PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOCYTE CLONE; PHENOTYPE; PRIORITY JOURNAL; TUMOR IMMUNITY;

ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CLONE CELLS; FLOW CYTOMETRY; HLA-A ANTIGENS; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES, CYTOTOXIC; WT1 PROTEINS;

EID: 33644862372     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.11.023     Document Type: Article

References (38)

1. M.A. Alexander-Miller, G.R. Leggatt, and J.A. Berzofsky Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy Proc. Natl. Acad. Sci. U. S. A. 93 1996 4102
2. J.D. Altman, P.A. Moss, P.J. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, J.I. Bell, A.J. McMichael, and M.M. Davis Phenotypic analysis of antigen-specific T lymphocytes Science 274 1996 94
3. S.R. Bennett, F.R. Carbone, F. Karamalis, R.A. Flavell, J.F. Miller, and W.R. Heath Help for cytotoxic-T-cell responses is mediated by CD40 signalling Nature 393 1998 478
4. M. Berard, K. Brandt, S. Bulfone-Paus, and D.F. Tough IL-15 promotes the survival of naive and memory phenotype CD8+ T cells J. Immunol. 170 2003 5018
5. L. Bergmann, C. Miething, U. Maurer, J. Brieger, T. Karakas, E. Weidmann, and D. Hoelzer High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome Blood 90 1997 1217
6. T. Boon, J.C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel Tumor antigens recognized by T lymphocytes Annu. Rev. Immunol. 12 1994 337
7. M. Cella, M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia Maturation, activation, and protection of dendritic cells induced by double-stranded RNA J. Exp. Med. 189 1999 821
8. A. Curti, E. Ferri, S. Pandolfi, A. Isidori, and R.M. Lemoli Dendritic cell differentiation J. Immunol. 172 2004 3 (with author reply)
9. M. Dauer, B. Obermaier, J. Herten, C. Haerle, K. Pohl, S. Rothenfusser, M. Schnurr, S. Endres, and A. Eigler Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors J. Immunol. 170 2003 4069
10. M. Dauer, K. Pohl, B. Obermaier, T. Meskendahl, J. Robe, M. Schnurr, S. Endres, and A. Eigler Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation Immunology 110 2003 38
11. M. Dauer, K. Schad, J. Herten, J. Junkmann, C. Bauer, R. Kiefl, S. Endres, and A. Eigler FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells J. Immunol. Methods 302 2005 145
12. H. Jonuleit, U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A.H. Enk Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur. J. Immunol. 27 1997 3135
13. W.C. Kieper, M. Prlic, C.S. Schmidt, M.F. Mescher, and S.C. Jameson Il-12 enhances CD8 T cell homeostatic expansion J. Immunol. 166 2001 5515
14. A. Lal, A.E. Lash, S.F. Altschul, V. Velculescu, L. Zhang, R.E. McLendon, M.A. Marra, C. Prange, P.J. Morin, K. Polyak, N. Papadopoulos, B. Vogelstein, K.W. Kinzler, R.L. Strausberg, and G.J. Riggins A public database for gene expression in human cancers Cancer Res. 59 1999 5403
15. A. Langenkamp, M. Messi, A. Lanzavecchia, and F. Sallusto Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells Nat. Immunol. 1 2000 311
16. A. Langenkamp, G. Casorati, C. Garavaglia, P. Dellabona, A. Lanzavecchia, and F. Sallusto T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification Eur. J. Immunol. 32 2002 2046
17. A.W. Lee, T. Truong, K. Bickham, J.F. Fonteneau, M. Larsson, I. Da Silva, S. Somersan, E.K. Thomas, and N. Bhardwaj A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy Vaccine 20 Suppl. 4 2002 A8
18. M. Little, G. Holmes, and P. Walsh WT1: what has the last decade told us? BioEssays 21 1999 191
19. D.H. Lynch, and R.E. Miller Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo J. Exp. Med. 179 1994 31
20. S. Mehrotra, R. Stevens, R. Zengou, N.G. Chakraborty, L.H. Butterfield, J.S. Economou, D.I. Dorsky, and B. Mukherji Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro Cancer Res. 63 2003 5607
21. J.D. Mintern, G.M. Davey, G.T. Belz, F.R. Carbone, and W.R. Heath Cutting edge: precursor frequency affects the helper dependence of cytotoxic T cells J. Immunol. 168 2002 977
22. B. Obermaier, M. Dauer, J. Herten, K. Schad, S. Endres, and A. Eigler Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes Biol. Proced. Online 5 2003 197
23. M. Oelke, U. Moehrle, J.L. Chen, D. Behringer, V. Cerundolo, A. Lindemann, and A. Mackensen Generation and purification of CD8+ Melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy Clin. Cancer Res. 6 2000 1997
24. M.J. Pittet, D. Valmori, P.R. Dunbar, D.E. Speiser, D. Lienard, F. Lejeune, K. Fleischhauer, V. Cerundolo, J.C. Cerottini, and P. Romero High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals J. Exp. Med. 190 1999 705
25. K. Polyak, and G.J. Riggins Gene discovery using the serial analysis of gene expression technique: implications for cancer research J. Clin. Oncol. 19 2001 2948
26. A. Reddy, M. Sapp, M. Feldman, M. Subklewe, and N. Bhardwaj A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells Blood 90 1997 3640
27. S.R. Riddell, and P.D. Greenberg The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells J. Immunol. Methods 128 1990 189
28. J.P. Ridge, F. Di Rosa, and P. Matzinger A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell Nature 393 1998 474
29. S.A. Rosenberg A new era for cancer immunotherapy based on the genes that encode cancer antigens Immunity 10 1999 281
30. K.S. Schluns, W.C. Kieper, S.C. Jameson, and L. Lefrancois Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo Nat. Immunol. 1 2000 426
31. C.S. Schmidt, and M.F. Mescher Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12 J. Immunol. 168 2002 5521
32. S.P. Schoenberger, R.E. Toes, E.I. van der Voort, R. Offringa, and C.J. Melief T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions Nature 393 1998 480
33. J.T. Tan, E. Dudl, E. LeRoy, R. Murray, J. Sprent, K.I. Weinberg, and C.D. Surh IL-7 is critical for homeostatic proliferation and survival of naive T cells Proc. Natl. Acad. Sci. U. S. A. 98 2001 8732
34. D. Valmori, J.F. Fonteneau, C.M. Lizana, N. Gervois, D. Lienard, D. Rimoldi, V. Jongeneel, F. Jotereau, J.C. Cerottini, and P. Romero Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues J. Immunol. 160 1998 1750
35. T.A. Waldmann The IL-2/IL-15 receptor systems: targets for immunotherapy J. Clin. Immunol. 22 2002 51
36. E.A. Walter, P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, E.D. Thomas, and S.R. Riddell Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N. Engl. J. Med. 333 1995 1038
37. S. Xu, G.K. Koski, M. Faries, I. Bedrosian, R. Mick, M. Maeurer, M.A. Cheever, P.A. Cohen, and B.J. Czerniecki Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism J. Immunol. 171 2003 2251
38. C. Yee, P.A. Savage, P.P. Lee, M.M. Davis, and P.D. Greenberg Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers J. Immunol. 162 1999 2227